Compare CVS Health Corp (CVS) vs Newegg Commerce Inc (NEGG) Price & Performance

CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.

The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.

NEGG trades at $13.87, down 1.98% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $4.88 million for 2025, though revenue improved to $1.44 billion. Recent news highlights AI shopping initiatives and the FantasTech sale, indicating ongoing business development efforts. Cash flow from operations remains negative at -$26.97 million, but financing activities provided a net cash inflow of $8.91 million.

The outlook is mixed; a single analyst rates NEGG a buy, and profitability may recover by 2026. However, persistent operating losses, weak cash generation, and high debt-to-asset ratios pose significant risks. Investors should weigh potential e-commerce growth against fundamental weaknesses and market volatility.